Market revenue in 2023 | USD 183.4 million |
Market revenue in 2030 | USD 339.1 million |
Growth rate | 9.2% (CAGR from 2023 to 2030) |
Largest segment | Anti-vegf agents |
Fastest growing segment | Anti-VEGF agents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Allergy, Anti-VEGF agents, Anti-inflammatory, Anti-glaucoma |
Key market players worldwide | Pfizer Inc, Alcon Inc, Novartis AG ADR, Bausch Health Companies Inc, Merck & Co Inc, Regeneron Pharmaceuticals Inc, AbbVie Inc, Bayer AG, Genentech, Nicox SA Share from reverse split, Coherus BioSciences Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic drugs market will help companies and investors design strategic landscapes.
Anti-vegf agents was the largest segment with a revenue share of 32.82% in 2023. Horizon Databook has segmented the Argentina ophthalmic drugs market based on anti-allergy, anti-vegf agents, anti-inflammatory, anti-glaucoma covering the revenue growth of each sub-segment from 2018 to 2030.
According to World Bank statistics from 2018, Argentina's current health spending, including health services, accounts for 9.62% of the country's annual GDP. Argentina lacks proper healthcare coverage; over 36% of its population does not have any formal healthcare coverage and is dependent on the public healthcare system.
An increase in the number of government initiatives, coupled with the rising incidence of retinal disease, is expected to drive the market over the forecast period. Moreover, environmental factors are contributing to the increasing retinal disease cases in the country.
The PAMI provides free healthcare to people aged 65 and older as well as resources such as support networks and immunization. According to World Bank data from 2018, the average life expectancy in the country is 76.52 years, which has been gradually growing since the establishment of PAMI.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina ophthalmic drugs market , including forecasts for subscribers. This country databook contains high-level insights into Argentina ophthalmic drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account